{"id":"W2963041253","doi":"10.1200/jco.19.00647","title":"Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Boniface Hospital","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; EMD Serono; Astellas Pharma; Syndax Pharmaceuticals; GlaxoSmithKline; Genentech; AstraZeneca; Pfizer","keywords":"Medicine; Capecitabine; Internal medicine; Breast cancer; Hazard ratio; Oncology; Chemotherapy; Cyclophosphamide; Cancer; Fluorouracil; Surgery; Confidence interval; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01328912,0.0008450691,0.002822107,0.000458762,0.0003661003,0.001606244,0.0006555376,0.001615917,0.00221704],"category_scores_gemma":[0.01304501,0.0004730666,0.002704545,0.0007287932,0.0006236827,0.0009213836,0.0005406066,0.003070476,0.0004444655],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001632655,"about_ca_system_score_gemma":0.001826742,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002747853,"about_ca_topic_score_gemma":0.007899821,"domain_scores_codex":[0.9930714,0.005412652,0.0003757499,0.0003633428,0.000552501,0.000224377],"domain_scores_gemma":[0.9927986,0.003572422,0.001769943,0.000503568,0.0005900713,0.0007654314],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8908374,0.001403587,0.004501923,0.003309652,0.008802379,0.0000949609,0.0001492464,0.001284526,0.001820244,0.0009781345,0.01060084,0.0762172],"study_design_scores_gemma":[0.9499938,0.01935263,0.008050636,0.0006848681,0.007556853,0.0001032037,0.00004004491,0.001170791,0.0003125455,0.0008181359,0.01187731,0.00003909631],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7576058,0.1825116,0.005007645,0.01946702,0.005900301,0.008609508,0.007842953,0.0003781499,0.012677],"genre_scores_gemma":[0.9098897,0.03848184,0.00762575,0.01634195,0.002498586,0.01082922,0.008500517,0.000114499,0.005718011],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01328912,"threshold_uncertainty_score":0.07028037,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02278549666162506,"score_gpt":0.3657898641321078,"score_spread":0.3430043674704828,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}